Lithium Carbonate Tablet, Film Coated, Extended Release
Product Images NDC 68462-223

2 FDA label images from Glenmark Pharmaceuticals Inc., Usa · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lithium Carbonate (NDC 68462-223). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Lbl300mg100s

Lbl300mg100s
Label for Lithium Carbonate Extended-Release Tablets USP, 300 mg strength, produced by Glenmark Pharmaceuticals Inc., USA. The label includes dosing form as film-coated extended-release tablets and package count of 100 tablets. Additional details include storage conditions, child safety warnings, and manufacturer information from Glenmark Pharmaceuticals Limited, India.*
FDA Label Image

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.